Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 6 INDUSTRY 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 108 Central Nervous System Neoplasms 42 Osteosarcoma 38 Gliosarcoma 34 Glioblastoma 34 Rhabdomyosarcoma 27 Lymphoma 22 Fibrosarcoma 22 Liposarcoma 21 Leiomyosarcoma 20 Neuroblastoma 19 Hemangiosarcoma 19 Astrocytoma 19 Sarcoma, Synovial 18 Neuroectodermal Tumors, Primitive, Peripheral 18 Dendritic Cell Sarcoma, Interdigitating 18 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Neurofibrosarcoma 17 Histiocytoma, Malignant Fibrous 17 Brain Neoplasms 17 Sarcoma, Kaposi 16 Malignant mesenchymal tumor 16 Burkitt Lymphoma 16 Ovarian Neoplasms 15 Recurrence 14 Leukemia 14 Sarcoma, Alveolar Soft Part 12 Oligodendroglioma 12 AIDS-related Kaposi sarcoma 12 Hemangiopericytoma, Malignant 11

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Solitary Fibrous Tumors × Sarcoma × Clear all

NCT03840772 2024-09-20

ERASING

Italian Sarcoma Group

Phase 2 Completed

Sarcoma, Solitary Fibrous Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡